Viavi Solutions is one of the best ways to play co-packaged optics and photonics, and the dilution-driven dip is a good entry. Viavi is raising $500M to repay its $450M Term Loan B, about 2% dilution that cleans up the balance sheet, yet shares fell almost 6% after hours. At roughly 39x 2027 estimates it is cheap versus photonics and CPO peers, and fundamentally less risky. CPO is a 2028-and-beyond story, so this is a longer-term holding. x.com x.com x.com x.com x.com



